Please login to the form below
ABPI
This page shows the latest ABPI news and features for those working in and with pharma, biotech and healthcare.
Trust – years to build, seconds to break and forever to repair
KISS (keep it simple stupid). Many companies and associations, like EFPIA and the ABPI, have been working to capitalise on the public’s thirst for knowledge that now exists, producing simple
Latest news
-
Matt Hancock unveils new National Institute for Health Protection
Preventative healthcare should be front and centre of plans for the NHS post COVID-19,” said Richard Torbett, chief executive of the Association of the British Pharmaceutical Industry (ABPI).
-
Delivering safe and effective clinical trials during the COVID-19 pandemic
It’s clear that COVID-19 will have many longstanding consequences. The ABPI has, for example, outlined some innovative ways that contract research organisations are adapting trials to the current circumstances.
-
UK ramps up measures to combat coronavirus spread
Richard Torbett, chief executive of the ABPI.
-
Chancellor’s ‘coronavirus budget’ also pledges big R&D gains
welcomed by the chief executive of the Association of the British Pharmaceutical Industry (ABPI), Dr Richard Torbett, as “critical to the future success of our industry”.
-
Brexit nears as Conservatives sweep to victory in election
In response to the Conservative victory, ABPI chief executive Mike Thompson (pictured right) said:. ... The ABPI supports these ambitions and we look forward to working with our members to bring new investment to the UK to further strengthen our
More from news
Approximately 96 fully matching, plus 503 partially matching documents found.
Latest Intelligence
-
Why pharma should invest in the education of doctors
The two most notable are compliance issues and budgeting. In order to meet the requirements of the ABPI’s Code of Practice, education has to be siloed from promotion.
-
Evolution or revolution: the latest review of NICE methods
It does look as though the industry, through the Association of the British Pharmaceutical Industry (ABPI), has got the edge on scoping – with the Working Committee tasked with setting the scope ... We can only expect that not everyone will be happy.
-
Mastering data protection in the pharma industry
The ABPI Pharmacovigilance Expert Network, the Pharmaceutical Information and Pharmacovigilance Association and pvlegal,.
-
Building European biotech firms to rival those of the US
the ABPI and BIA are lobbying hard to preserve links with the EU.
-
How can we realise the benefits of patient engagement?
From EFPIA to the ABPI, guidance for working with patients and patient organisations is clear: pharma can and should engage with this important stakeholder.
More from intelligence
Approximately 8 fully matching, plus 49 partially matching documents found.
Latest appointments
-
Roudie Shafie joins OVID Health’s senior team as director
Shafie's previous experience includes roles at the ABPI and Pfizer UK. ... Shafie’s career experience includes time spent as head of government affairs at the ABPI and corporate public affairs lead for Pfizer UK.
-
Neurocentrx appoints two members to the board
His career history has seen him work in private equity and venture capital and he has been president of the ABPI.
-
Professor Carole Longson moves from NICE to the ABPI
Longson brings research, academic and pharmaceutical industry experience to the ABPI, including seven years as a research lead at GlaxoSmithKline. ... experience, expertise and network in both industry and academia will enable the ABPI to work with our
-
HCA appoints Mike Dixon as its new CEO
Commenting on behalf of the HCA Executive Committee, ABPI executive director of communications Aileen Thompson said: “We are really pleased that Mike has decided to lead the HCA at this critical
-
AZ's Lisa Anson elected president of ABPI
year. Anson joined the ABPI board in 2012 and has since overseen a number of schemes for the association, including the implementation of the Pharmaceutical Pricing Regulation Scheme. ... Speaking on behalf of the board and all staff at the ABPI, we very
More from appointments
Approximately 21 fully matching, plus 13 partially matching documents found.
Latest from PMHub
-
How can your exhibition stand maximise customer engagement?
But where do you go from there, especially within the ABPI guidelines?
-
A patient view on the ABPI’s patient collaboration sourcebook
Last month, the ABPI released a much-in-demand document: The Working with Patients and Patient Organisations sourcebook. ... Last month, the ABPI released a much-in-demand document: T he Working with Patients and Patient Organisations sourcebook.
-
Modern alternatives to banner exhibition stands (why a reusable pharma exhibition stand could save you money)
Or a handy phone charger to draw people in. Of course, you’ll also need to be aware of any company restrictions, pharma industry regulations (ABPI), and local country regulations.
-
Pharma exhibition stand design: size doesn’t have to matter
Of course, you’ll also need to be aware of any company restrictions, pharma industry regulations (ABPI), and local country regulations.
-
Making a Difference - The Future of Pharma
On a global scale, pharma is one of the least-trusted industries. And this is despite the fact that pharma contributes more than £30 BN each year to the UK economy, supports almost 500, 000 jobs in the UK alone, and donated 1.4 BN treatments to the
More from PMHub
Approximately 3 fully matching, plus 22 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Gavi says 76 wealthy countries have committed to COVAX vaccine facility
- Gilead agrees $21bn buyout of Immunomedics
- 20 for 2020 – Five pharma companies to watch
- FDA approves Roche’s Actemra COVID-19 trial
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Could formulary intelligence be your brand differentiator?
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Porterhouse Medical strengthens its senior management team
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....
Latest intelligence
- Could formulary intelligence be your brand differentiator?
- Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
Quick links
Infographics
